MedPath

AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.

AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

Conditions
HIV
Interventions
Other: Antiretroviral Therapy Interruption(ATI)
First Posted Date
2022-09-15
Last Posted Date
2022-12-02
Lead Sponsor
American Gene Technologies International Inc.
Target Recruit Count
7
Registration Number
NCT05540964
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Washington Health Institute, Washington, District of Columbia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Georgetown University, Washington, District of Columbia, United States

Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T

Conditions
HIV
First Posted Date
2022-09-07
Last Posted Date
2022-12-02
Lead Sponsor
American Gene Technologies International Inc.
Target Recruit Count
7
Registration Number
NCT05529342
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Georgetown University, Washington, District of Columbia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Washington Health Institute, Washington, District of Columbia, United States

Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy

Phase 1
Completed
Conditions
HIV
Interventions
Biological: AGT103-T
First Posted Date
2020-09-23
Last Posted Date
2023-04-12
Lead Sponsor
American Gene Technologies International Inc.
Target Recruit Count
7
Registration Number
NCT04561258
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Georgetown University, Washington, District of Columbia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Washington Health Institute, Washington, District of Columbia, United States

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

Conditions
HIV Infections
First Posted Date
2017-07-12
Last Posted Date
2020-09-16
Lead Sponsor
American Gene Technologies International Inc.
Target Recruit Count
24
Registration Number
NCT03215004
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Institute of Human Virology, University of Maryland Baltimore, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Providence Hospital, Washington, District of Columbia, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath